ENG and breast cancer: In relation to this result, we observed that the group of patients with high expression of CD105 mRNA had a lower proportion of luminal B subtype breast cancer compared to the group with low expression (29.63% vs. 52.94%, respectively, p = 0.009) (Figures 5A,B).